Principal Investigator
Henry Moore
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20260132
Clinical Trial Summary
Phase 2, double-blind, placebo-controlled study to evaluate the effectiveness of two doses of AP-472 as adjunctive therapy to levodopa in Parkinsons disease (PD) participants with motor fluctuations
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Wilfredo Rodriguez Somoza
Phone Number
+1 (561) 9394169
Email
wxr205@miami.edu